FEBUCURE 40

About

FEBUCURE 40 contains Febuxostat, a xanthine oxidase inhibitor used for the long-term management of hyperuricemia in patients with gout. It works by reducing the production of uric acid in the body, thereby preventing the formation of uric acid crystals in joints and tissues, which are responsible for gout flares. By lowering serum uric acid levels, Febuxostat helps to decrease the frequency and severity of gout attacks and can aid in the dissolution of existing tophi.

It is an important therapeutic option for patients who cannot tolerate or do not respond adequately to allopurinol. Consistent use as prescribed is crucial for effective long-term control of gout and prevention of its complications.

Uses

• Chronic management of hyperuricemia in gout patients.
• Prevention of gout flares.
• Reduction of serum uric acid levels.
• Dissolution of uric acid crystals and tophi.

Directions For Use

Take one tablet daily, with or without food, as prescribed by your doctor. Do not stop taking it without consulting your physician.

Benefits

• Effectively lowers uric acid levels.
• Reduces frequency of gout attacks.
• Helps dissolve existing tophi.
• Improves long-term gout management.
• Alternative for allopurinol intolerant patients.
• Enhances quality of life for gout sufferers.

Side Effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Skin rash
• Joint pain
• Liver function abnormalities
• Gout flares (initial)
• Chest pain
• Palpitations
• Fatigue
• Edema

Safety Measures

• Alcohol - Limit alcohol intake as it can increase uric acid levels and counteract the effects of Febuxostat.
• Pregnancy - Not recommended during pregnancy due to insufficient data on human fetal safety. Use only if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding - It is unknown if Febuxostat passes into breast milk. Therefore, it is generally not recommended during breastfeeding. Consult a doctor.
• Liver - Use with caution in patients with mild to moderate liver impairment. Regular monitoring of liver function tests is recommended. Avoid in severe liver disease.
• Kidney - Use with caution in patients with mild to moderate kidney impairment. No dose adjustment is typically needed for mild to moderate, but close monitoring is advised.
• Lung - No specific precautions for lung conditions are generally noted, but always inform your doctor about all existing medical conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.